3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Esophagitis
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Etoposide
31
Carboplatin
30
atezolizumab
17
durvalumab
16
Cisplatin
14
Topotecan
11
PM 01183
11
Specimen Handling
9
pembrolizumab
8
Magnetic Resonance Spectroscopy
7
olaparib
5
Radiotherapy
5
berzosertib
4
anlotinib
4
Paclitaxel
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Temozolomide
3
Radiosurgery
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
AMG 757
3
sacituzumab govitecan
2
monalizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Immunonutrition Diet
×
90 days
×
Clear all
NCT06840704
2026-04-02
Relief
Hunan Cancer Hospital
Phase 3
Recruiting
121 enrolled